Skip to main content
Clinical Trials/NCT04560855
NCT04560855
Completed
Not Applicable

Secure Self-monitoring Through a Combination of Connected Objects: Implementation in COVID-19 Patients Monitored at Home

Withings4 sites in 1 country10 target enrollmentSeptember 14, 2020
ConditionsCovid19

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Withings
Enrollment
10
Locations
4
Primary Endpoint
Sensitivity and Specificity of the patient's aggravation with a cluster model
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Currently, COVID+ infected patients who are on ambulatory home monitoring self-assess their health status simply by completing questionnaires and measuring their temperature twice a day. The SECURADOM project proposes to facilitate the follow-up of COVID+ or suspected COVID+ infected patients, followed at home, by collecting clinical signs on a telephone application and to monitor physiological safety parameters (respiratory rate, heart rate, temperature, blood pressure, activity) using connected objects developed by the company WITHINGS. This daily monitoring, which can be transmitted by patients to the doctors in charge of their surveillance, will improve the quality and safety of home monitoring.

Registry
clinicaltrials.gov
Start Date
September 14, 2020
End Date
May 12, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Withings
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Adults, men and women, 18 y/o or more
  • Patient diagnosed COVID positive with RT-PCR positive or very suggestive symptoms and a contagion (contact with sick subjects) that can be managed on an outpatient basis.
  • Patient in possession of a smartphone (with Android or iOS) allowing the installation of the Withings Health Mate application
  • Patient with access to an internet connection for the use of Withings connected products at the containment site
  • Voluntary patient who has not objected to his or her participation
  • Patient affiliated to or beneficiary of a social security scheme

Exclusion Criteria

  • Pregnant Women
  • Patient with severe symptoms requiring hospitalization as recommended by the French Ministry of Health (23/03/2020)
  • Patient without social protection or affiliated to the AME (State Medical Aid)
  • Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure (patient under guardianship or curatorship) Articles L1121-5 to L1121-8
  • Patient who, in the judgment of the investigator, may not be cooperative or respectful of the obligations inherent to participation in the study.

Outcomes

Primary Outcomes

Sensitivity and Specificity of the patient's aggravation with a cluster model

Time Frame: 1 year

The sensitivity and specificity of a cluster model based on the vital parameters retrieved from the connected devices will be calculated in order to evaluate its performance

Sensitivity and Specificity of the patient's aggravation with a logistic regression model

Time Frame: 1 year

The sensitivity and specificity of a logistic regression model based on the vital parameters retrieved from the connected devices will be calculated in order to evaluate its performance

Secondary Outcomes

  • Study the evolution of daily patient parameters without aggravation over time(1 year)
  • Subjective assessment of the connected devices(1 year)

Study Sites (4)

Loading locations...

Similar Trials